Results 231 to 240 of about 1,864,473 (295)
The Neurological Impact of Metabolic and Bariatric Surgery: A Systematic Review of Post-Operative Neuropathic and Non-Neuropathic Complications. [PDF]
Thirumalai S +7 more
europepmc +1 more source
Abstract figure legend During GLP‐1RA treatment reduced appetite and energy intake, delayed gastric emptying, decreased visceral fat mass and improved glycaemic control contribute to weight loss. After treatment cessation these benefits are partially or completely reversed, resulting in weight regain, accompanied by increased appetite and energy intake,
Camille E. M. Piguet +2 more
wiley +1 more source
Abdominal Wall Hernia After Metabolic and Bariatric Surgery: A Narrative Review. [PDF]
Kim Y, Kim KH, Lee SH, Moon Y, Seo KW.
europepmc +1 more source
Spontaneous Hyperinflation of Intragastric Balloon Presenting as Acute Pancreatitis
ABSTRACT Obesity is a metabolic disorder with considerable health implications affecting populations worldwide. Intragastric balloon (IGB) placement has gained popularity as a minimally invasive and reversible management option for obesity. Although generally safe, IGBs can sometimes be associated with serious adverse outcomes. We present a case of IGB
Ong Yan Ling +2 more
wiley +1 more source
Interpreting Pain-Mood Associations in a Secondary Analysis of a Bariatric Surgery Trial [Letter]. [PDF]
Wang H, Liu A.
europepmc +1 more source
ABSTRACT Endoscopic submucosal dissection (ESD) has become an established therapeutic approach for duodenal adenomas, although it is technically demanding. Duodenal mucosal resurfacing (DMR) is an emerging endoscopic metabolic therapy designed to ablate and regenerate duodenal mucosa. To date, no reports have described ESD including the papilla (ESDIP)
Chi‐Chu Lo +5 more
wiley +1 more source
Effects of bariatric surgery on non-invasive markers of MASLD: a retrospective analysis. [PDF]
Lukolic I +8 more
europepmc +1 more source
Serious Adverse Events in Adult ICU Patients: A Substudy of the PATIENCE Cohort
ABSTRACT Introduction Prokinetic agents are used to enhance upper gastrointestinal motility, but adverse events related to these agents are poorly described. We aimed to provide detailed epidemiological data on predefined serious adverse events (SAEs) in a cohort of adult intensive care unit (ICU) patients with and without prokinetic treatment.
Vera Crone +13 more
wiley +1 more source

